Tuesday 15 July 2014   13:30 – 15:00
Track 2 - Optimizing anti-epilepsy drug discovery

Chair: Michele Simonato
Co-Chair: Terence O'Brien

Defining the clinical “gaps to care” and the “opportunities” to develop new treatments for epilepsy
Terence O'Brien

Technical and methodological issues
Aristea Galanopoulou

Development of anti-epileptogenic therapies
Asla Pitkanen

Use of biomarkers and surrogate endpoints.
Jerome Jr. Engel